Med-El
Med-El is a Private Indian company incorporated in 1989 and based in Delhi, India. Med-El operates in Medical & Precision (NIC 33112) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
MED-EL - Middle ear & Cochlear implants and Hearing aids.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Med-El.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +17d | filed |
| MGT-7 | FY2024-25 | 24 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 23 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 26 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Med-El.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 884531138 | HDFC Bank Ltd(Bank) | ₹5.76 Cr | 12 Mar 2019 | Open |
| 336869646 | HDFC Bank Ltd(Bank) | ₹10.00 Cr | 19 Sep 2023 | Satisfied |
| 622255146 | State Bank of India(Bank) | ₹11.04 Cr | 12 Mar 2022 | Open |
| 944367103 | State Bank of India(Bank) | ₹23.64 Cr | 04 Jul 2021 | Open |
Charge IDs, lenders & amounts for Med-El.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹18.02 Cr | ₹56.40 L | ₹8.57 Cr | ₹23.29 Cr | 54 |
| FY2023-24 | ₹15.13 Cr | ₹60.18 L | ₹9.85 Cr | ₹16.94 Cr | 28 |
| FY2022-23 | ₹13.83 Cr | ₹39.90 L | ₹8.72 Cr | ₹21.71 Cr | 145 |
| FY2021-22 | ₹10.90 Cr | ₹22.26 L | ₹5.72 Cr | ₹11.78 Cr | 146 |
Audited financials & ratios for Med-El.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹18.02 Cr | ₹15.13 Cr | ₹13.83 Cr | ₹10.90 Cr |
| Other income | ₹31.67 L | ₹59.67 L | ₹39.42 L | ₹7.35 L |
| Total income | ₹18.34 Cr | ₹15.72 Cr | ₹14.22 Cr | ₹10.97 Cr |
| Total expenses | ₹17.61 Cr | ₹14.95 Cr | ₹13.71 Cr | ₹10.68 Cr |
| Profit before tax | ₹73.32 L | ₹78.23 L | ₹51.86 L | ₹28.93 L |
| Profit / (Loss) after tax | ₹56.40 L | ₹60.18 L | ₹39.90 L | ₹22.26 L |
| Balance sheet | ||||
| Equity / Net worth | ₹8.57 Cr | ₹9.85 Cr | ₹8.72 Cr | ₹5.72 Cr |
| Borrowings | ₹7.10 Cr | ₹2.37 Cr | ₹4.18 Cr | ₹1.97 Cr |
| Current liabilities | ₹6.75 Cr | ₹3.35 Cr | ₹4.89 Cr | ₹3.08 Cr |
| Total liabilities | ₹14.72 Cr | ₹7.10 Cr | ₹12.99 Cr | ₹6.05 Cr |
| Current assets | ₹11.73 Cr | ₹5.95 Cr | ₹7.69 Cr | ₹5.63 Cr |
| Cash & equivalents | ₹1.98 Cr | ₹1.90 Cr | ₹2.14 Cr | ₹1.01 Cr |
| Total assets | ₹23.29 Cr | ₹16.94 Cr | ₹21.71 Cr | ₹11.78 Cr |
| Employees | 54 | 28 | 145 | 146 |
Audited financials & ratios for Med-El.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹18.02 Cr | -10.5% | -5.1% | +4.5% |
| Profit after Tax | ₹56.40 L | +13.8% | -2.0% | +4.2% |
| Net Worth | ₹8.57 Cr | -7.7% | +14.0% | -1.6% |
| Employees | 54 | +33.5% | +21.8% | +4.8% |
Audited financials & ratios for Med-El.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹18.02 Cr | ₹56.40 L | +3.13% | +31.51% | +6.58% | +2.42% | 0.83 | ₹33.37 L |
| FY2023-24 | ₹15.13 Cr | ₹60.18 L | +3.98% | -8.39% | +6.11% | +3.55% | 0.24 | ₹54.02 L |
| FY2022-23 | ₹13.83 Cr | ₹39.90 L | +2.89% | +39.40% | +4.58% | +1.84% | 0.48 | ₹9.53 L |
| FY2021-22 | ₹10.90 Cr | ₹22.26 L | +2.04% | +7.89% | +3.89% | +1.89% | 0.34 | ₹7.46 L |
Audited financials & ratios for Med-El.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 2,17,80,461 | 90.60% |
| Institutional Investors | 2 | 9,77,686 | 4.07% |
| Public & Others | 52 | 12,81,772 | 5.33% |
Promoter, institutional & public holding for Med-El.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
675 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.